相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunobiology of mesenchymal stem cells
S. Ma et al.
CELL DEATH AND DIFFERENTIATION (2014)
Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury
Mogeli S. Khubutiya et al.
CYTOTHERAPY (2014)
High Mobility Group Box 1 Inhibits Human Pulmonary Artery Endothelial Cell Migration via a Toll-like Receptor 4- and Interferon Response Factor 3-dependent Mechanism(s)
Eileen M. Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Methods Employed for Induction and Analysis of Experimental Myocardial Infarction in Mice
Oliver Borst et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material
Ramin Lotfi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Hepatocyte growth factor twenty years on: Much more than a growth factor
Takahiro Nakamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues
Christopher D. Gregory et al.
JOURNAL OF PATHOLOGY (2011)
HMGB1 and Cord Blood: Its Role as Immuno-Adjuvant Factor in Innate Immunity
Alessandra Ciucci et al.
PLOS ONE (2011)
PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia
Katsuto Tamai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HMGB proteins: Interactions with DNA and chromatin
Michal Stros
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Hmgb1 Promotes Wound Healing of 3T3 Mouse Fibroblasts via Rage-Dependent ERK1/2 Activation
Elia Ranzato et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2010)
Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells
Sebastian Vogel et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation
Guangxu Zhu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Extracellular High Mobility Group Box-1 (HMGB1) Inhibits Enterocyte Migration via Activation of Toll-like Receptor-4 and Increased Cell-Matrix Adhesiveness
Shipan Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
High-mobility group protein box-1 and its relevance to cerebral ischemia
Qing-wu Yang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
Ruth S. Waterman et al.
PLOS ONE (2010)
Sterile inflammation: sensing and reacting to damage
Grace Y. Chen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke
Permphan Dharmasaroja
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells
Lara Campana et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-beta and Protein Kinase R
Christiane A. Opitz et al.
STEM CELLS (2009)
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein
Hirotaka Kazama et al.
IMMUNITY (2008)
Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury
Thorsten Trapp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mesenchymal stem cells and cardiac repair
Catharina Nesselmann et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2008)
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling
Francesco Liotta et al.
STEM CELLS (2008)
High Mobility Group Box 1 Protein Inhibits the Proliferation of Human Mesenchymal Stem Cells and Promotes Their Migration and Differentiation along Osteoblastic Pathway
Erhong Meng et al.
STEM CELLS AND DEVELOPMENT (2008)
Mesenchymal stem cells in health and disease
Antonio Uccelli et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities
Luca Mollica et al.
CHEMISTRY & BIOLOGY (2007)
High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells
Emmanouil Chavakis et al.
CIRCULATION RESEARCH (2007)
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
De Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The secretion of HMGB1 is required for the migration of maturing dendritic cells
Ingrid E. Dumitriu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The extracellular release of HMGB1 during apoptotic cell death
Charles W. Bell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Cellular immunity of patients with malignant glioma:: prerequisites for dendritic cell vaccination immunotherapy
Marion Rapp et al.
JOURNAL OF NEUROSURGERY (2006)
Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia
Richard S. Goldstein et al.
SHOCK (2006)
Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine
S Mitola et al.
JOURNAL OF IMMUNOLOGY (2006)
Neural stem cell migration toward gliomas in vitro
O Heese et al.
NEURO-ONCOLOGY (2005)
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival
K Urbanek et al.
CIRCULATION RESEARCH (2005)
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
IE Dumitriu et al.
JOURNAL OF IMMUNOLOGY (2005)
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing
S Neuss et al.
STEM CELLS (2004)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies
N Quirici et al.
EXPERIMENTAL HEMATOLOGY (2002)
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
B Degryse et al.
JOURNAL OF CELL BIOLOGY (2001)
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
T Nakamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets
M Aoki et al.
GENE THERAPY (2000)